<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-383</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9612</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRACTICE</subject></subj-group></article-categories><title-group><article-title>Уровни сывороточных провоспалительных цитокинов у детей с перинатальным контактом по HCV-инфекции</article-title><trans-title-group xml:lang="en"><trans-title>Serum inflammatory cytokine levels in children with perinatal HCV infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1083-2807</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Первишко</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pervishko</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Первишко Олеся Валерьевна, к.м.н., доцент, заведующая кафедрой педиатрии №1</p><p>350063, Краснодар, ул. Митрофана Седина, д. 4</p></bio><bio xml:lang="en"><p>Olesya V. Pervishko, Сand. Sci. (Med.), Associate Professor, Head of the Department of Pediatrics No. 1</p><p>4, Mitrofan Sedin St., Krasnodar, 350063</p></bio><email xlink:type="simple">ole-pervishko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4200-4598</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарова</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharova</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захарова Ирина Николаевна, д.м.н., профессор, Заслуженный врач России, заведующая кафедрой педиатрии имени академика Г.Н. Сперанского</p><p>125993, Москва, ул. Баррикадная, д. 2/1, стр. 1</p></bio><bio xml:lang="en"><p>Irina N. Zakharova, Dr. Sci. (Med.), Professor, Honored Doctor of Russia, Head of the Department of Pediatrics named after Academician G.N. Speransky</p><p>2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993</p></bio><email xlink:type="simple">zakharova-rmapo@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кубанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российская медицинская академия непрерывного профессионального образования</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuous Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2025</year></pub-date><volume>0</volume><issue>19</issue><elocation-id>255–261</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Первишко О.В., Захарова И.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Первишко О.В., Захарова И.Н.</copyright-holder><copyright-holder xml:lang="en">Pervishko O.V., Zakharova I.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9612">https://www.med-sovet.pro/jour/article/view/9612</self-uri><abstract><sec><title>Введение</title><p>Введение. Поиск биомаркеров, участвующих в формировании хронического вирусного гепатита С у детей, позволит определить дальнейший прогноз данной серьезной патологии.</p></sec><sec><title>Цель</title><p>Цель. Изучить и оценить уровни сывороточных провоспалительных цитокинов IL-1β, IL-6, IL-18, TNF-α у детей раннего возраста с перинатальным контактом по HCV-инфекции.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено ретроспективное наблюдательное исследование: 1-я группа: 59 детей до 3 лет с наличием перинатального контакта по HCV-инфекции; 2-я группа – 28 пациентов с наличием реализовавшего хронического вирусного гепатита С, 3-я группа – группа контроля, составили 30 «условно здоровых» детей. Уровень провоспалительных цитокинов (IL-1β, IL-6, IL-18, TNF-α) изучали в сыворотке крови с использованием ИФА-метода и тест-систем Вектор-Бест (г. Санкт-Петербург).</p></sec><sec><title>Результаты</title><p>Результаты. У детей 1-й группы отмечалось достоверное увеличение IL-6 до 2,278 пг/мл (р = 0,003), а концентрация IL-18 имела достоверно более низкие значения в сравнении со здоровыми детьми (р &lt; 0,05). IL-1β и TNF-α находились на уровне контрольных значений – р = 0,115 и р = 0,448 соответственно. Результаты логистической регрессии определили, что при увеличении IL-18 на 1 пг/мл у пациентов 1-й группы вероятность формирования перинатального контакта уменьшалась в 1,29 раза. Данные результаты свидетельствуют об участии IL-18 в механизмах реализации хронических форм HCVинфекции. Пациенты 2-й группы имели достоверное увеличение IL-1β, IL-6, TNF-α (p &lt; 0,001), IL-18 (p &lt; 0,05).</p></sec><sec><title>Выводы</title><p>Выводы. Дисбаланс цитокинов в крови детей 1-й группы характеризовался избытком IL-6 и недостатком IL-18 при нормальном содержании IL-1β и TNF-α. У пациентов 2-й группы уровни всех изучаемых цитокинов были достоверно выше уровня контроля. Следовательно, определение уровней сывороточных концентраций IL-6, IL-18 могут быть использованы для мониторинга и прогнозирования развития ХВГС.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The search for biomarkers involved in the formation of chronic viral hepatitis C in children will allow us to determine the further prognosis of the pathology.</p></sec><sec><title>Аim</title><p>Аim. To study and evaluate the levels of serum proinflammatory cytokines IL-1β, IL-6, IL-18, TNF-α in young children with perinatal contact for HCV infection.</p></sec><sec><title>Materials and мethods</title><p>Materials and мethods. A retrospective observational study was conducted: Group 1 included 59 children under 3 years of age with perinatal exposure to HCV infection; Group 2 included 28 patients with established chronic hepatitis C; and Group 3, a control group consisting of 30 "conditionally healthy" children. Serum levels of proinflammatory cytokines (IL-1β, IL-6, IL-18, and TNF-α) were measured using ELISA and the Vector-Best test system (St Petersburg).</p></sec><sec><title>Results</title><p>Results. In children with perinatal HCV contact, there was a significant increase in IL-6 to 2.278 pg/ml (p = 0.003), while the concentration of IL-18 was significantly lower compared to healthy children (p &lt; 0.05). IL-1β and TNF-α were at the level of control values, p = 0.115 and p = 0.448, respectively. The results of logistic regression determined that with an increase in IL-18 by 1 pg/ml in patients with perinatal contact for HCV infection, the probability of formation of perinatal contact decreased by 1.29 times. These results indicate the participation of IL-18 in the mechanisms of the implementation of chronic forms of HCV infection. Patients with the realized chronic viral hepatitis C had a significant increase in IL-1β, IL-6, TNF-α (p &lt; 0.001), IL-18 (p &lt; 0.05).</p></sec><sec><title>Conclusion</title><p>Conclusion. The imbalance of cytokines in the blood of children with perinatal HCV contact was characterized by an excess of IL-6 and a deficiency of IL-18, with normal levels of IL-1β and TNF-α. In patients with chronic viral hepatitis C, the levels of all studied cytokines were significantly higher than in the control group. Determination of serum concentrations can be used to monitor and predict the development of chronic hepatitis C.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>перинатальный контакт по HCV-инфекции</kwd><kwd>провоспалительные цитокины</kwd><kwd>IL-1β</kwd><kwd>IL-6</kwd><kwd>TNF-α</kwd><kwd>IL-18</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>perinatal contact with HCV infection</kwd><kwd>and pro-inflammatory cytokines</kwd><kwd>IL-1β</kwd><kwd>IL-6</kwd><kwd>TNF-α</kwd><kwd>IL-18</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dieye NL, Varol M, Zorich SC, Millen AE, Yu KOA, Gómez-Duarte OG. Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York. BMC Gastroenterol. 2023;23(1):242. https://doi.org/10.1186/s12876-023-02871-8.</mixed-citation><mixed-citation xml:lang="en">Dieye NL, Varol M, Zorich SC, Millen AE, Yu KOA, Gómez-Duarte OG. Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York. BMC Gastroenterol. 2023;23(1):242. https://doi.org/10.1186/s12876-023-02871-8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host-Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4):376. https://doi.org/10.3390/cells8040376.</mixed-citation><mixed-citation xml:lang="en">Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host-Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4):376. https://doi.org/10.3390/cells8040376.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">García-Romero CS, Guzmán C, Martínez-Ibarra A, Cervantes A, Serbon M. Viral hepatitis in pregnant Mexican women: its impact on the binomial health of mother and child and strategies for its eradication. Pathogens. 2024;13(8):651. https://doi.org/10.3390/pathogens13080651.</mixed-citation><mixed-citation xml:lang="en">García-Romero CS, Guzmán C, Martínez-Ibarra A, Cervantes A, Serbon M. Viral hepatitis in pregnant Mexican women: its impact on the binomial health of mother and child and strategies for its eradication. Pathogens. 2024;13(8):651. https://doi.org/10.3390/pathogens13080651.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кравченко ЕН, Куклина ЛВ, Шевлюкова ТП. Внутриутробная инфекция: факторы риска и проблемы диагностики во время беременности. Акушерство и гинекология: новости, мнения, обучение. 2023;11(4):35–44. https://doi.org/10.33029/2303-9698-2023-11-4-35-44.</mixed-citation><mixed-citation xml:lang="en">Kravchenko EN, Kuklina LV, Shevlyukova TP. Intrauterine infection: risk factors and diagnostic problems during pregnancy. Akusherstvo i Ginekologiya: Novosti, Mneniya, Obuchenie. 2023;11(4):35–44. (In Russ.) https://doi.org/10.33029/2303-9698-2023-11-4-35-44.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Terrault NA, Levy MT, Cheung KW, Jourdain G. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol. 2021;18(2):117–130. https://doi.org/10.1038/s41575-020-00361-w.</mixed-citation><mixed-citation xml:lang="en">Terrault NA, Levy MT, Cheung KW, Jourdain G. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol. 2021;18(2):117–130. https://doi.org/10.1038/s41575-020-00361-w.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gounden V, Vashisht R, Jialal I. Hypoalbuminemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available at: https://pubmed.ncbi.nlm.nih.gov/30252336.</mixed-citation><mixed-citation xml:lang="en">Gounden V, Vashisht R, Jialal I. Hypoalbuminemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available at: https://pubmed.ncbi.nlm.nih.gov/30252336.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Тийс РП, Осипова ЛП. Интерлейкин-6: его роль в организме, генетический полиморфизм и значение при некоторых заболеваниях (литературный обзор). Медицинская генетика. 2022;21(1):14–27. https://doi.org/10.25557/2073-7998.2022.01.14-27.</mixed-citation><mixed-citation xml:lang="en">Tiis RP, Osipova LP. Interleukin-6: it’s role in the organism, genetic polymorphism and significance in certain diseases (literature review). Medical Genetics. 2022;21(1):14–27. (In Russ.) https://doi.org/10.25557/2073-7998.2022.01.14-27.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Noh I, Avoi R, Nurul A, Ahmad I, Bakar R. Analysis of serum and gene expression profile of cytokines (IL-6, TNF-α and TGF-b1) in chronic hepatitis C virus infection. PeerJ. 2022;10:e13330. https://doi.org/10.7717/peerj.13330.</mixed-citation><mixed-citation xml:lang="en">Noh I, Avoi R, Nurul A, Ahmad I, Bakar R. Analysis of serum and gene expression profile of cytokines (IL-6, TNF-α and TGF-b1) in chronic hepatitis C virus infection. PeerJ. 2022;10:e13330. https://doi.org/10.7717/peerj.13330.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 2025;10(1):33. https://doi.org/10.1038/s41392-024-02072-z.</mixed-citation><mixed-citation xml:lang="en">Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 2025;10(1):33. https://doi.org/10.1038/s41392-024-02072-z.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology. 2009;128(1):e514–е522. https://doi.org/10.1111/j.1365-2567.2008.03021.x.</mixed-citation><mixed-citation xml:lang="en">Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology. 2009;128(1):e514–е522. https://doi.org/10.1111/j.1365-2567.2008.03021.x.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Лобзин ЮВ, Грешнякова ВА, Рычкова СВ, Горячева ЛГ, Баликин ВФ, Волынец ГВ и др. Хронический вирусный гепатит С (ХВГС) у детей: клинические рекомендации. 2024. Режим доступа: https://algom.ru/post/nkr00824-Hronicheskii_virusnii_gepatit_S_(HVGS)_u_detei__2024_g__(odobreno_NPS_MZ_RF)?lang=.</mixed-citation><mixed-citation xml:lang="en">Лобзин ЮВ, Грешнякова ВА, Рычкова СВ, Горячева ЛГ, Баликин ВФ, Волынец ГВ и др. Хронический вирусный гепатит С (ХВГС) у детей: клинические рекомендации. 2024. Режим доступа: https://algom.ru/post/nkr00824-Hronicheskii_virusnii_gepatit_S_(HVGS)_u_detei__2024_g__(odobreno_NPS_MZ_RF)?lang=.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Z, Wang Y. Viral and host factors associated with the outcomes of hepatitis C virus infection (review). Mol Med Rep. 2017;15(5):2909–2924. https://doi.org/10.3892/mmr.2017.6351.</mixed-citation><mixed-citation xml:lang="en">Yang Z, Wang Y. Viral and host factors associated with the outcomes of hepatitis C virus infection (review). Mol Med Rep. 2017;15(5):2909–2924. https://doi.org/10.3892/mmr.2017.6351.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Yang Z, Ye K. Interleukin-6 Gene Polymorphisms and Susceptibility to Liver Diseases: A Meta-Analysis. Medicine. 2019;98(50):1–13. https://doi.org/10.1097/MD.0000000000018408.</mixed-citation><mixed-citation xml:lang="en">Wang H, Yang Z, Ye K. Interleukin-6 Gene Polymorphisms and Susceptibility to Liver Diseases: A Meta-Analysis. Medicine. 2019;98(50):1–13. https://doi.org/10.1097/MD.0000000000018408.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Raba T. Proinflammatory Cytokines IL-2, IL-6 and TNF -Alpha as Immunoseralogic Indicators of Chronic Viral Hepatitis B and C in Children. Univer J Med Sci. 2018;6(1):1–7. https://doi.org/10.13189/ujmsj.2018.060101.</mixed-citation><mixed-citation xml:lang="en">Raba T. Proinflammatory Cytokines IL-2, IL-6 and TNF -Alpha as Immunoseralogic Indicators of Chronic Viral Hepatitis B and C in Children. Univer J Med Sci. 2018;6(1):1–7. https://doi.org/10.13189/ujmsj.2018.060101.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence determines CD8 T cell immunodominance and tissue changes leading to distinct developmental stages. J Virol. 2003;77(8):4911–4927. https://doi.org/10.1128/jvi.77.8.4911-4927.2003.</mixed-citation><mixed-citation xml:lang="en">Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence determines CD8 T cell immunodominance and tissue changes leading to distinct developmental stages. J Virol. 2003;77(8):4911–4927. https://doi.org/10.1128/jvi.77.8.4911-4927.2003.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670–684. https://doi.org/10.1016/j.immuni.2007.09.006.</mixed-citation><mixed-citation xml:lang="en">Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670–684. https://doi.org/10.1016/j.immuni.2007.09.006.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4):376. https://doi.org/10.3390/cells8040376.</mixed-citation><mixed-citation xml:lang="en">Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019;8(4):376. https://doi.org/10.3390/cells8040376.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH et al. Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun. 2017;18(2):82–87. https://doi.org/10.1038/gene.2017.2.</mixed-citation><mixed-citation xml:lang="en">Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH et al. Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun. 2017;18(2):82–87. https://doi.org/10.1038/gene.2017.2.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yang C, Liu Z, Yang Y, Cocka LJ, Li Y, Zeng W, Shen H. Chronic viral infection impairs immune memory to a different pathogen. PLoS Pathog. 2024;20(3):e1012113. https://doi.org/10.1371/journal.ppat.1012113</mixed-citation><mixed-citation xml:lang="en">Yang C, Liu Z, Yang Y, Cocka LJ, Li Y, Zeng W, Shen H. Chronic viral infection impairs immune memory to a different pathogen. PLoS Pathog. 2024;20(3):e1012113. https://doi.org/10.1371/journal.ppat.1012113</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
